Parexel has enhanced its clinical data service offering with the addition of new features to further support data collection and analysis as well as adaptive trial design.
Ireland-based CRO Icon has agreed, subject to certain closing conditions, to acquire Aptiv Solutions for $143.5m in cash to further expand its adaptive trial offerings.
Perceptive Informatics, the eClinical solutions provider and Parexel subsidiary, has released the results of a global survey which shows a growing interest in the implementation of adaptive trial designs.
Definitive FDA guidance on adaptive trials cannot come soon enough for the pharmaceutical and biotech sectors, according to Perceptive Informatics (PI).